(800)525-7111 Free Consultation

dangerous drugs

Zantac Lawsuit Update

February 12, 2020   |  
A federal judiciary panel has sent 140 Zantac lawsuits to the Southern District of Florida, where they will be consolidated into Multidistrict Litigation (MDL) proceedings. According to the United States Panel on Multidistrict Litigation, lawsuits alleging that Zantac causes cancer “could be a large litigation.” The Zantac lawsuits allege that...
Read More

100 Billion Pain Pills: Report Casts Alarming New Light on Opioid Crisis

January 19, 2020   |  
More than 100 billion doses prescription painkillers oxycodone and hydrocodone were shipped throughout the United States from 2006 to 2014, according to disturbing new data from the Drug Enforcement Agency (DEA). The report was released by the government following an extensive legal challenge by The Washington Post and the Charleston...
Read More

Pharmacies File Opioid Lawsuit Against Doctors in Ohio

January 10, 2020   |  
Major drug store chains have filed a lawsuit against hundreds of medical doctors in Ohio, claiming that they overprescribed painkillers and bear at least partial responsibility for the opioid epidemic. These opioid lawsuits are just the latest in a series of legal action involving opioid manufacturers, distributors, pharmacies and, now,...
Read More

Zantac Recall: Potential Zantac Cancer Risk from NDMA

January 8, 2020   |  
The FDA has issued a blanket Zantac recall covering brand name Zantac and generic equivalents containing ranitidine. In October 2019, the FDA warned that Zantac (otherwise known by its generic name, ranitidine) may contain elevated levels of NDMA, a chemical that can potentially cause cancer. ***UPDATE: A Zantac recall has...
Read More

11th-Hour Opioid Lawsuit Settlement Averts Ohio Trial

October 21, 2019   |  
Four major opioid manufacturers have agreed to settle an opioid lawsuit brought by Ohio counties in a deal worth $260 million. First reported by the Wall Street Journal, the settlement averts a jury trial that was scheduled to begin today. Defendants in the lawsuit, McKesson Corp., AmerisourceBergen, and Cardinal Health...
Read More

Another One: Johnson & Johnson Agrees to $20.4 Million Opioid Lawsuit Settlement

October 4, 2019   |  
Major pharmaceutical manufacturer Johnson & Johnson this week announced it would pay $20.4 million to settle opioid lawsuits brought by two Ohio counties. The settlement arrives just before a landmark federal trial combining thousands of opioid lawsuits begins in October. Of the $20.4 million, Johnson & Johnson will pay $10...
Read More

Zantac Cancer Risk and Potential Recall for NDMA

October 1, 2019   |  
Does Zantac cause cancer? With evidence indicating a possible cancer risk, Walgreens, CVS and Rite-Aid have stopped selling Zantac and ranitidine, a generic version of the popular heartburn medication. Many people are asking "I heard the Zantac I've been taking could cause Cancer. Is that true?" According to a review...
Read More

Purdue Pharma Reaches Tentative Opioid Lawsuit Settlement

September 13, 2019   |  
Purdue Pharma, the maker of OxyContin, has reached a tentative settlement with 27 states and territories in a lawsuit alleging the opioid manufacturer helped fuel the opioid crisis. The deal is valued at nearly $12 billion. Despite the announcement, 20 other state attorneys general have not agreed to the deal....
Read More

Johnson & Johnson Opioid Trial: Company Ordered to Pay $572 Million

August 27, 2019   |  
An Oklahoma judge has issued a verdict in a closely watched Johnson & Johnson opioid trial, ordering the pharmaceutical company to pay $572 million to the State of Oklahoma for its role in fueling the opioid crisis. In his ruling, Cleveland County District Judge Thad Balkman wrote that Johnson &...
Read More

Allergan and Endo Settle Opioid Lawsuit for $15 million

August 26, 2019   |  
Two major opioid manufacturers have agreed to settle an Ohio opioid lawsuit alleging that Endo International PLC and Allergan PLC helped cause the U.S. opioid epidemic. The companies agreed to pay $15 million to two Ohio counties and provide up to $1 million in two pharmaceutical drugs at no cost....
Read More